Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) has cumulatively repurchased shares totaling 1.23%, amounting to 61.09 million yuan.
Guizhou Sanli (603439.SH) announced that on September 20, 2024, the company completed a transaction through voluntary trading...
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that as of September 20, 2024, the company had repurchased a total of 5.0317 million shares through centralized bidding trading, accounting for 1.23% of the total share capital of the company as of the date of this announcement. The highest repurchase price was RMB 13.12 per share, and the lowest repurchase price was RMB 11.71 per share, with a total amount of funds used for repurchase of RMB 61.0931 million (excluding transaction costs).
Related Articles
US Stock Market Move | Apple Inc. lowers commission rate for Chinese App Store; Tencent (ADR) up nearly 2% in early trading.
US Stock Market Move | "The launch of the new AI model 'Avocado' by Meta (META.US) is postponed, causing a nearly 3% drop in early trading."
Fantasia Group successfully restructured its overseas debt of USD 4.655 billion through a combination of various tools to alleviate debt pressure.
US Stock Market Move | Apple Inc. lowers commission rate for Chinese App Store; Tencent (ADR) up nearly 2% in early trading.
US Stock Market Move | "The launch of the new AI model 'Avocado' by Meta (META.US) is postponed, causing a nearly 3% drop in early trading."
Fantasia Group successfully restructured its overseas debt of USD 4.655 billion through a combination of various tools to alleviate debt pressure.
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026
